TU Dresden and BIOTRONIK expand their strategic cooperation in teaching and research

New "Biomedical Engineering" degree programme prepares graduates for the medical technology of tomorrow

TU Dresden (TUD) and the medical technology company BIOTRONIK are intensifying their cooperation within the framework of the newly introduced "Biomedical Engineering" degree programme. This innovative degree programme places a special focus on future-oriented fields of research in medical technology, such as telemedicine, e-health and radiation applications. The specialisations are closely aligned with the economic sectors of Dresden, Saxony and the region. The degree programme was introduced at the TUD a year ago and currently has more than 100 students.

"Our aim is to provide students with an in-depth understanding of the latest technologies and their practical application. We rely on practical collaborations with leading companies such as the medical technology manufacturer BIOTRONIK to give students an insight into current trends in cardiovascular medical technology," says Prof. Hagen Malberg, Dean of Studies Biomedical Engineering and Director of the Institute of Biomedical Engineering (IBMT).

Prof. Andreas Arndt, Professor of System Integration and Scientific Instrumentation at TUD and Deputy Director of the Kurt Schwabe Institute for Measurement and Sensor Technology Meinsberg e.V., emphasises: "Thanks to the cooperation with BIOTRONIK, we can offer students a specialised seminar on pacemaker technology. They come into contact with cutting-edge cardiovascular implants and learn about the future topics of medical technology that are currently being researched." "The students learn more about current trends such as e-health and the application of AI-supported data analysis in the field of cardiovascular diseases," adds Dr. Martin Schmidt, group leader at the IBMT.

TU Dresden and BIOTRONIK are also working on the above-mentioned topics in the TIMELY project, which is being led by the University of Amsterdam and in which both partners are actively involved. The EU-funded project is developing an AI-based platform for high-risk patients with coronary heart disease that enables doctors to carry out an automated risk assessment of their patients' state of health using electronically transmitted vital data. Patients at risk can thus be closely monitored using telemedicine - even from home.

Roberto Belke, Managing Director of BIOTRONIK Germany and himself a TUD graduate, explains: "We have realised how fruitful collaboration with different partners from non-university research, universities and industry can be. We are therefore now continuing our successful collaboration with TU Dresden in other areas too."

Both partners are already planning new projects for the care of heart patients using telemedicine and artificial intelligence. The collaboration should help to sustainably improve medical care and incorporate the latest research findings directly into teaching.

Contact:

Prof. Dr.-Ing. habil. Hagen Malberg
Institute of Biomedical Engineering
Chair for Biomedical Engineering
+49 351 463-35040

Prof. Dr.-Ing. Andreas Arndt
Institute of Solid State Electronics
Chair for System Integration and Scientific Instrumentation
+49 351 463 4 3782

Dr.-Ing. Martin Schmidt
Institute of Biomedical Engineering
Biosignal Processing Group
+49 351 463-39942

About BIOTRONIK:

At BIOTRONIK, the well-being of patients is our top priority - and has been for 60 years. BIOTRONIK is one of the world's leading medical technology companies. Our products and services save and improve the lives of millions of people with cardiovascular diseases and chronic pain. We innovate and develop reliable cardiovascular, endovascular and neuromodulation solutions with the goal of perfectly matching technology to individual patient needs. BIOTRONIK is headquartered in Berlin and is present in more than 100 countries.